1310366-15-4

Basic information

• Product Name: tert-butyl N-(2-bromobenzenesulfonyl)-N-acetyloxy-carbamate
• Synonyms: tert-butyl N-(2-bromobenzenesulfonyl)-N-acetyloxy-carbamate
• CAS NO: 1310366-15-4
• Molecular Weight: 394.243
• Mol File: 1310366-15-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: tert-butyl N-(2-bromobenzenesulfonyl)-N-acetyloxy-carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl N-(2-bromobenzenesulfonyl)-N-acetyloxy-carbamate(1310366-15-4)
• EPA Substance Registry System: tert-butyl N-(2-bromobenzenesulfonyl)-N-acetyloxy-carbamate(1310366-15-4)

Safety Data

• Hazardous Substances Data: 1310366-15-4(Hazardous Substances Data)

Upstream product

• 99768-83-9 (acetyloxy)carbamic acid 1,1-dimethyl ethyl ester 
• 2905-25-1 o-bromobenzenesulfonyl chloride 
• 36016-38-3 tert-Butyl N-hydroxycarbamate 

Downstream Products

• 576-92-1 bromobenzene-2-sulfonic acid 
• 1310366-71-2 N-acetyloxy-2-bromobenzenesulfonamide 
• 1352414-80-2 N',N'-dimethyl-N-2-bromo-benzenesulfonyl-N-acetoxy-carbamide 
• 1352414-78-8 N-(2-bromobenzenesulfonyl)-N-acetyloxy-2,2,2-trimethylacetamide 
• 1352414-77-7 N-(2-bromobenzenesulfonyl)-N-acetyloxy-2,2-dimethylacetamide 
• 1310366-00-7 N-(2-bromobenzenesulfonyl)-N-acetyloxy-acetamide 

Relevant articles and documents

Bis-Acylated Hydroxylamine Derivatives

The invention provides certain bis-acylated hydroxylamine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the invention provides methods of using such compounds or pharmaceutical compositions for treating, preventing, or delaying the onset and/or develop of a disease or condition. In some embodiments, the disease or condition is selected from cardiovascular diseases, ischemia, reperfusion injury, cancerous disease, pulmonary hypertension and conditions responsive to nitroxyl therapy.